IL36G and colorectal carcinoma: Quantitative analysis demonstrated that IL-36α, IL-36β or IL-36γ were reduced by 60, 80% or 70% in the CRC tissues, compared to that of patient-matched non-cancer colonic tissue, respectively (P < 0.001) (Fig. 1a, d, g).